Status: Not yet recruiting
Reducing Co-occurring Substance Use and HIV Risk Among Stimulant-using Men at High Risk for HIV in the United States of America.
This intervention will focus on stimulant-using men at high risk for HIV who are in need of tailored behavioral interventions to mitigate co-occurring stimulant use and HIV risk in the era of pre-exposure prophylaxis (PrEP). The study is a pilot randomized controlled trial to evaluate the adaptation, feasibility, acceptability, and preliminary efficacy of a behavioral intervention.
Participants needed: 84
Trial details
Age: 18+Biological sex: MaleType: InterventionalSponsor: University of FloridaUpdated: Jun 30, 2026
Eligibility criteria
be 18 years of age or older; [+5]
display diminished capacity to consent (e.g., cognitive impairment); or [+4]